| 時間 | 主題 | 講者 | 座長 | 摘要 | 簡報 |
|---|---|---|---|---|---|
13:10 ~ 13:30 |
瀏覽海報時間 |
All |
張英勛, 王紹全 |
||
13:30 ~ 13:34 |
MP03-01: Treatment strategy for dialysis patient with urothelial carcinoma |
楊浩誌 |
張英勛, 王紹全 |
||
13:34 ~ 13:38 |
MP03-02: The pan-immune-inflammation value is a new prognostic biomarker in upper tract urothelial carcinoma |
郁廉靖 |
張英勛, 王紹全 |
||
13:38 ~ 13:42 |
MP03-03: New treatment strategies for overcoming the chemoresistance of urothelial carcinoma |
許富順 |
張英勛, 王紹全 |
||
13:42 ~ 13:46 |
MP03-04: Cost-effectiveness analysis of immune checkpoint inhibitors in metastatic urothelial cancer, a single-center retrospective study |
楊立宇 |
張英勛, 王紹全 |
||
13:46 ~ 13:50 |
MP03-05: Aquaporins are involved in tumor formation and may potentially act as a therapeutic target in urothelial carcinoma |
葉碧雯 |
張英勛, 王紹全 |
||
13:50 ~ 13:54 |
MP03-06: Effects of variant histology on the oncology outcomes of patients with upper tract urothelial carcinoma after radical nephroureterectomy |
于宗玉 |
張英勛, 王紹全 |
||
13:54 ~ 13:58 |
MP03-07: The role of lymph node dissection in patients with upper tract urothelial carcinoma without clinical lymph node metastasis undergoing radical nephroureterectomy |
邱泰樺 |
張英勛, 王紹全 |
||
13:58 ~ 14:02 |
MP03-08: Blockade of the autophagic flux suppresses antitumor immunity via programmed death ligand-1 up-regulation in bladder cancer |
蔡德甫 |
張英勛, 王紹全 |
||
14:02 ~ 14:06 |
MP03-09: Second primary malignancy risk in patients with upper urinary tract urothelial carcinoma in Taiwan - a nationwide population-based study |
郭育任 |
張英勛, 王紹全 |
||
14:06 ~ 14:10 |
MP03-10: Establishing predictive model of renal function after unilateral nephroureterectomy in upper tract urothelial carcinoma patients |
蘇楷森 |
張英勛, 王紹全 |